Drug Profile
Leptin - Oramed Pharmaceuticals
Alternative Names: Oral leptin capsule - Oramed Pharmaceuticals; ORMD-0701Latest Information Update: 28 Jul 2022
Price :
$50
*
At a glance
- Originator Oramed Pharmaceuticals
- Class Adipokines; Anorectics; Antihyperglycaemics; Obesity therapies; Peptide hormones; Small molecules
- Mechanism of Action Leptin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Obesity; Type 1 diabetes mellitus
Most Recent Events
- 28 Jul 2022 No recent reports of development identified for clinical-Phase-Unknown development in Type-1 diabetes mellitus in Israel (PO, Capsule)
- 28 Jun 2021 No recent reports of development identified for preclinical development in Obesity in Israel (PO, Capsule)
- 25 Jun 2021 Pharmacokinetics from a clinical trial in Type-1 diabetes mellitus presented at the 81st Annual Scientific Sessions of the American Diabetes Association by Oramed (ADA-2021)